Abhishek Srivastava
Nessuna posizione attualmente
Patrimonio netto: 145 $ in data 31/03/2024
Profilo
Abhishek Srivastava is currently working as Vice President-Technical Operations at Alaunos Therapeutics, Inc. He previously worked as Vice President-Cell Therapy Development at Athenex, Inc. He holds a doctorate degree from the University of Louisville School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/03/2023 | 80 ( 0.00% ) | 145 $ | 31/03/2024 |
Precedenti posizioni note di Abhishek Srivastava
| Società | Posizione | Fine |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2023 |
| ATHENEXPAR | Corporate Officer/Principal | - |
Formazione di Abhishek Srivastava
| University of Louisville School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Borsa valori
- Insiders
- Abhishek Srivastava
